Thursday, May 6, 2021

Fwd: J&J blood clot in Utah

The first case of a rare blood-clotting condition thought to be linked to the Johnson & Johnson COVID-19 vaccine has been diagnosed in Utah.

A male patient was recently diagnosed with vaccine-induced Thrombotic Thrombocytopenia, also known as VITT, at the University of Utah Hospital, U. health officials said in a Wednesday news release.

The patient, who is under the age of 50, was treated and is now recovering at home, according to Dr. Yazan Abou-Ismail, an assistant professor of medicine in the Division of Hematology at the University of Utah.

"He continues to do well and feel well," Abou-Ismail said at a Wednesday news conference about the case.

The blood clot condition led to a nationwide pause on administration of the Johnson & Johnson vaccine last month after six cases were reported among over 6 million people who received the vaccine. The pause was lifted on April 23 after federal regulators determined the vaccine's continued use is safe.

First case of rare blood-clotting condition linked to J&J vaccine diagnosed in Utah; CDC reports 17 cases from 8M doses | KSL.com


No comments:

Post a Comment